Loading organizations...
Loading organizations...
Precision antibiotic therapies using naturally occurring bacteriocins.
Glox Therapeutics has raised $7.3M across 3 funding rounds.
Glox Therapeutics has raised $7.3M in total across 3 funding rounds.
Glox Therapeutics has raised $7.3M in total across 3 funding rounds.
Glox Therapeutics's investors include LifeArc, Pace Ventures, Boehringer Ingelheim, Scottish Enterprise.
Glox Therapeutics has raised $7.3M across 3 funding rounds. Most recently, it raised $670K Grant in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 21, 2025 | $670K Grant | LifeArc | |
| Nov 20, 2024 | $1.3M Grant | Pace Ventures | |
| Nov 14, 2023 | $5.3M Seed | Boehringer Ingelheim, Scottish Enterprise |